OAC
TEVA icon

OMERS Administration Corp’s Teva Pharmaceuticals TEVA Stock Holding History

OMERS Administration Corp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-28,100
Closed -$568K – 1334
2025
Q3 		$568K Buy
+28,100
New +$494K ﹤0.01% 709
2025
Q2 		– Sell
-21,947
Closed -$337K – 1083
2025
Q1 		$337K Hold
21,947
– – ﹤0.01% 834
2024
Q4 		$484K Sell
21,947
-6,753
-24% -$123K ﹤0.01% 711
2024
Q3 		$517K Buy
+28,700
New +$502K ﹤0.01% 654

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

OMERS Administration Corp's TEVA Position: Q4 2025 in Review

OMERS Administration Corp sold out of Teva Pharmaceuticals (TEVA) in Q4 2025, closing a stake of 28,100 shares — an estimated $568K sold.

OMERS Administration Corp first reported a position in TEVA in Q3 2024 and held it in 4 quarters. The position peaked at $568K in Q3 2025. 631 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

  • OMERS Administration Corp reported no remaining Teva Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 28,100 Teva Pharmaceuticals shares in Q4 2025, an estimated $568K.
  • OMERS Administration Corp first reported a position in Teva Pharmaceuticals in Q3 2024 and held it in 4 quarters.
  • OMERS Administration Corp's Teva Pharmaceuticals position peaked at $568K in Q3 2025.
  • 631 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.